New Evidence for Placebell and Compl-AI in Type 1 Diabetes
At the recent 2025 Advanced Technologies & Treatments for Diabetes congress in Amsterdam, Cognivia presented two new scientific posters demonstrating…
News
News
Insights
Discussion on the Use of Placebell and FDA’s Feedback
Cognivia recently initiated a discussion with the FDA through the “Innovative Science and Technology Approaches for New Drugs…
Events
Cognivia to Host Webinar on FDA’s Draft Guidance for Diversity in Clinical Trials
Cognivia is pleased to announce an upcoming webinar focused on strategies for aligning with the FDA’s recent draft…
News
Cognivia Predictive Algorithm for More Personalized Neuropathic Pain Treatment
Alternative and safe therapeutic approaches for neuropathic pain are needed. Interdisciplinary and collaborative research is essential to advance…
News
Cognivia USA Inc. Expansion into US Market to Advance Clinical Research with Predictive Patient Insights
Cognivia is thrilled to announce the strategic expansion of its subsidiary, Cognivia USA Inc., into the US market….
News
Cognivia Announces Strategic Additions to Propel Clinical Research Innovation
Cognivia, an emerging leader in the drug development ecosystem, is committed to making a significant impact in the…